Showing results (341-350 of 384) with videos related to
Sort By:
Pageof 39
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 2015
Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapyHye Won Lee, Jung-Il Lee, Se Jeong Lee, et al.Neuro-Oncology Advances|July 21, 2021
Radiological assessment schedule for 1p/19q-codeleted gliomas during the surveillance period using parametric modelingHo Kang, Jongjin Lee, So Young Ji, et al.Cancer Research and Treatment|November 2, 2019
Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)Kihwan Hwang, Tae Min Kim, Chul-Kee Park, et al.Neoplasia (New York, N.Y.)|March 27, 2023
Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5Hye-Min Jeon, Young Taek Oh, Yong Jae Shin, et al.Therapeutic Advances in Medical Oncology|June 16, 2020
First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patientsSeung Tae Kim, Jung Yong Hong, Se Hoon Park, et al.Cancer Research and Treatment|July 8, 2021
Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study)Grace S Ahn, Kihwan Hwang, Tae Min Kim, et al.Brain : a Journal of Neurology|March 22, 2012
Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signallingXun Jin, Sung-Hak Kim, Hye-Min Jeon, et al.Journal of Neuro-Oncology|November 6, 2010
Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trialIl Han Kim, Chul-Kee Park, Dae Seog Heo, et al.Molecular Cancer Therapeutics|November 21, 2015
GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR LigandsYangmi Lim, Jiho Yoo, Min-Soo Kim, et al.Nature Cell Biology|September 12, 2018
A tension-mediated glycocalyx-integrin feedback loop promotes mesenchymal-like glioblastomaJ Matthew Barnes, Shelly Kaushik, Russell O Bainer, et al.Pageof 39